Nephrogenic fibrosing dermopathy with systemic involvement
- PMID: 12873886
- DOI: 10.1001/archderm.139.7.903
Nephrogenic fibrosing dermopathy with systemic involvement
Abstract
Background: There is a growing literature regarding sclerotic and panniculitic cutaneous conditions seen in patients with end-stage renal disease (eg, calciphylaxis and soft tissue calcification). Nephrogenic fibrosing dermopathy (NFD) is a recent designation to describe cutaneous findings in patients with end-stage renal disease who developed sclerotic plaques with scleromyxedema-like histologic features. Soft tissue calcification is rare in patients with NFD and systemic involvement has not been reported.
Observations: We describe a patient with end-stage renal disease who developed diffuse indurated woody plaques consistent with NFD in association with soft tissue calcification with catastrophic sequelae. A deep excisional biopsy specimen from the patient revealed thickened collagen bundles in the reticular dermis, plump bipolar spindle cells, and increased mucin. Focally, there were zones of calcium deposition in dermal collagen without vessel calcification. Autopsy of the patient revealed extensive fibrosis and calcification of the diaphragm, psoas muscle, renal tubules, and rete testes. The patient died 11 months after developing NFD.
Conclusion: A subset of patients with NFD may have significant systemic involvement.
Comment in
-
What nephrogenic fibrosing dermopathy might be.Arch Dermatol. 2003 Jul;139(7):928-30. doi: 10.1001/archderm.139.7.928. Arch Dermatol. 2003. PMID: 12873893 No abstract available.
Similar articles
-
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.J Am Acad Dermatol. 2006 Feb;54(2 Suppl):S31-4. doi: 10.1016/j.jaad.2005.04.024. J Am Acad Dermatol. 2006. PMID: 16427988
-
Nephrogenic fibrosing dermopathy.Dermatol Online J. 2008 May 15;14(5):11. Dermatol Online J. 2008. PMID: 18627747
-
Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.J Cutan Pathol. 2010 Feb;37(2):204-10. doi: 10.1111/j.1600-0560.2009.01301.x. J Cutan Pathol. 2010. PMID: 19341434
-
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.Int J Dermatol. 2007 May;46(5):447-52. doi: 10.1111/j.1365-4632.2007.03301.x. Int J Dermatol. 2007. PMID: 17472669 Review.
-
Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis.Int J Dermatol. 2006 Jan;45(1):56-9. doi: 10.1111/j.1365-4632.2005.02701.x. Int J Dermatol. 2006. PMID: 16426379 Review.
Cited by
-
Immunologic and nonimmunologic sclerodermal skin conditions - review.Front Immunol. 2023 Jul 12;14:1180221. doi: 10.3389/fimmu.2023.1180221. eCollection 2023. Front Immunol. 2023. PMID: 37600771 Free PMC article. Review.
-
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.Tex Heart Inst J. 2022 May 1;49(3):e217680. doi: 10.14503/THIJ-21-7680. Tex Heart Inst J. 2022. PMID: 35612906 Free PMC article. Review.
-
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.Histochem Cell Biol. 2021 Jan;155(1):19-73. doi: 10.1007/s00418-020-01919-0. Epub 2020 Oct 11. Histochem Cell Biol. 2021. PMID: 33040183
-
Updated guidelines for intravenous contrast use for CT and MRI.Emerg Radiol. 2020 Apr;27(2):115-126. doi: 10.1007/s10140-020-01751-y. Epub 2020 Jan 10. Emerg Radiol. 2020. PMID: 31925592 Review.
-
Gadolinium-based contrast agents: why nephrologists need to be concerned.Curr Opin Nephrol Hypertens. 2019 Mar;28(2):154-162. doi: 10.1097/MNH.0000000000000475. Curr Opin Nephrol Hypertens. 2019. PMID: 30531473 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
